Crater in pharmaceutical stocks as investors brace for legal action
Shares of GlaxoSmithKline, Sanofi and Haleon all sold off sharply this week, losing tens of billions in market value, amid investor fear of possible US lawsuits centered on the popular heartburn drug Zantac. It’s a known issue that’s been languishing in the background for years, but investor concern exploded this week as the first court
READ MORE